Key Events This Week
3 Aug: New 52-week and all-time high at Rs.5,249.95
4 Aug: Minor recovery with a 0.22% gain
5-7 Aug: Consecutive declines culminating in a 2.96% weekly fall

Torrent Pharmaceuticals Ltd. Hits New 52-Week High of Rs 5249.95 on Back of Strong Technical Signals
2026-08-03 09:44:32From a 52-week low of Rs 3,480 to a fresh peak of Rs 5,249.95, Torrent Pharmaceuticals Ltd. has surged 51% over the past year, significantly outperforming the Sensex which declined by 2.43% in the same period. This milestone reflects a powerful technical momentum that has propelled the stock to new heights despite a broadly mixed market backdrop.
Read full news article
Torrent Pharmaceuticals Ltd. Hits All-Time High of Rs 5,249.95 as Momentum Builds Across Timeframes
2026-08-03 09:34:14Extending its recent gains, Torrent Pharmaceuticals Ltd. touched a fresh all-time high of Rs 5,249.95 on 03 Aug 2026, marking a significant milestone in its market journey amid a broadly bullish technical backdrop.
Read full news article
Torrent Pharmaceuticals Ltd. is Rated Hold
2026-08-02 10:10:16Torrent Pharmaceuticals Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 22 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 August 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Read full news articleTorrent Pharmaceuticals Gains 2.88%: 5 Key Factors Driving the Week’s Momentum
2026-08-02 09:01:13
Key Events This Week
27 Jul: Stock opens strong at Rs.5,017.05 (+1.15%) amid positive market sentiment
28 Jul: Sharp decline of 2.35% to Rs.4,899.30 on heavy volume
31 Jul: Torrent hits new 52-week and all-time high at Rs.5,139.3, closing at Rs.5,102.80 (+4.77%)
31 Jul: Surge in call option activity at Rs.5,000 strike price ahead of August expiry
31 Jul: Q1 FY27 results reveal strong revenue growth but margin and debt concerns
Are Torrent Pharmaceuticals Ltd. latest results good or bad?
2026-07-31 19:19:44Torrent Pharmaceuticals Ltd. has reported its financial results for Q1 FY27, showcasing a significant growth in net sales but a more modest increase in net profit. The company achieved net sales of ₹4,921 crores, reflecting a year-on-year growth of 54.85% and a sequential increase of 17.25%. This growth appears to be largely driven by recent acquisitions, which have contributed to the highest quarterly revenue in the company's history. In contrast, net profit for the same quarter was ₹566 crores, representing only a 3.28% increase year-on-year, although it showed a substantial sequential growth of 55.49% from the previous quarter. The disparity between revenue and profit growth can be attributed to a significant rise in interest expenses and depreciation charges, which surged dramatically due to the company's recent acquisition activities. Interest expenses rose to ₹305 crores from ₹56 crores a year ago, w...
Read full news article
Broad-Based Technical Strength Lifts Torrent Pharmaceuticals Ltd. to 52-Week High of Rs 5139.3
2026-07-31 12:10:21With a decisive surge to Rs 5139.3 on 31 Jul 2026, Torrent Pharmaceuticals Ltd. has reached a fresh 52-week high, marking a 36.13% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and a market environment where the Sensex trades modestly higher, underscoring the stock’s outperformance within the Pharmaceuticals & Biotechnology sector.
Read full news article
Torrent Pharmaceuticals Ltd. Hits All-Time High of Rs 5,115 as Momentum Accelerates
2026-07-31 11:51:57Extending its winning streak after a brief pause, Torrent Pharmaceuticals Ltd. surged 5.02% on 31 Jul 2026 to close at a fresh all-time high of Rs 5,115, outpacing the Sensex which inched up just 0.12% on the day.
Read full news article
Torrent Pharmaceuticals Ltd. Rallies 3.55% and Approaches 52-Week High Amid Strong Technical Setup
2026-07-31 11:21:22The Sensex edged up 0.1% on 31 Jul 2026, but Torrent Pharmaceuticals Ltd. outperformed decisively with a 3.55% gain, touching an intraday high of Rs 5,047.20. This 2.8 percentage-point outperformance over its sector signals a stock-specific strength rather than a broad market lift.
Read full news articleTorrent Pharmaceuticals Limited - Other General Purpose
18-Nov-2019 | Source : NSETorrent Pharmaceuticals Limited has informed the Exchange regarding Compliance as per Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Torrent Pharmaceuticals Limited - Updates
05-Nov-2019 | Source : NSETorrent Pharmaceuticals Limited has informed the Exchange regarding Clarification on Media Reports
Torrent Pharmaceuticals Limited - Analysts/Institutional Investor Meet/Con. Call Updates
22-Oct-2019 | Source : NSETorrent Pharmaceuticals Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
Corporate Actions
No Upcoming Board Meetings
Torrent Pharmaceuticals Ltd. has declared 180% dividend, ex-date: 29 May 26
Torrent Pharmaceuticals Ltd. has announced 5:10 stock split, ex-date: 20 Feb 06
Torrent Pharmaceuticals Ltd. has announced 1:1 bonus issue, ex-date: 08 Jul 22
No Rights history available






